These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 16718753)

  • 21. Role of serotonergic and noradrenergic systems in a model of visceral pain.
    Korzeniewska-Rybicka I; Płaźnik A
    Pol J Pharmacol; 2001; 53(5):475-80. PubMed ID: 11990065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility.
    Gershon MD
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():3-14. PubMed ID: 15521849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dyspepsia: organic versus functional.
    Oustamanolakis P; Tack J
    J Clin Gastroenterol; 2012 Mar; 46(3):175-90. PubMed ID: 22327302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis and therapy for idiopathic dyspepsia.
    Tack J; Kindt S
    Curr Gastroenterol Rep; 2005 Dec; 7(6):437-44. PubMed ID: 16313872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastrointestinal sensory abnormalities in functional dyspepsia.
    Schmulson MJ; Mayer EA
    Baillieres Clin Gastroenterol; 1998 Sep; 12(3):545-56. PubMed ID: 9890087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of serotonin in the pathophysiology of the irritable bowel syndrome.
    Crowell MD
    Br J Pharmacol; 2004 Apr; 141(8):1285-93. PubMed ID: 15100164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent insights into digestive motility in functional dyspepsia.
    Mizuta Y; Shikuwa S; Isomoto H; Mishima R; Akazawa Y; Masuda J; Omagari K; Takeshima F; Kohno S
    J Gastroenterol; 2006 Nov; 41(11):1025-40. PubMed ID: 17160514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noradrenergic and serotonergic abnormalities in depression: stress-induced dysfunction?
    Dinan TG
    J Clin Psychiatry; 1996; 57 Suppl 4():14-8. PubMed ID: 8636061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the abnormalities of gastroduodenal functions in functional dyspepsia.
    Domínguez-Muñoz JE
    Dig Dis; 2001; 19(3):195-200. PubMed ID: 11752837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastroduodenal motility.
    Tack J; Janssen P
    Curr Opin Gastroenterol; 2010 Nov; 26(6):647-55. PubMed ID: 20838344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastric and autonomic responses to stress in functional dyspepsia.
    Camilleri M; Malagelada JR; Kao PC; Zinsmeister AR
    Dig Dis Sci; 1986 Nov; 31(11):1169-77. PubMed ID: 2945708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional findings in irritable bowel syndrome.
    Posserud I; Ersryd A; Simrén M
    World J Gastroenterol; 2006 May; 12(18):2830-8. PubMed ID: 16718806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathophysiology of functional dyspepsia.
    Lee KJ; Kindt S; Tack J
    Best Pract Res Clin Gastroenterol; 2004 Aug; 18(4):707-16. PubMed ID: 15324709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Placebo in functional dyspepsia: symptomatic, gastrointestinal motor, and gastric sensorial responses.
    Mearin F; Balboa A; Zárate N; Cucala M; Malagelada JR
    Am J Gastroenterol; 1999 Jan; 94(1):116-25. PubMed ID: 9934741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New considerations in the treatment of functional dyspepsia].
    Herszényi L; Juhász M; Tulassay Z
    Orv Hetil; 2004 Apr; 145(14):747-54. PubMed ID: 15131990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New drugs for the treatment of functional dyspepsia].
    Troncon LE
    Arq Gastroenterol; 2001; 38(3):207-12. PubMed ID: 11917722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional gastroduodenal disorders.
    Talley NJ; Stanghellini V; Heading RC; Koch KL; Malagelada JR; Tytgat GN
    Gut; 1999 Sep; 45 Suppl 2(Suppl 2):II37-42. PubMed ID: 10457043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Visceral sensitivity disturbances in the pathogenesis of functional gastrointestinal disorders].
    Mazur M; Furgała A; Thor PJ
    Folia Med Cracov; 2004; 45(1-2):33-49. PubMed ID: 16276824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Functional dyspepsia].
    Feinle C; Fried M
    Ther Umsch; 1997 Nov; 54(11):629-34. PubMed ID: 9454364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A placebo-controlled trial of the 5-HT1A agonist R-137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia.
    Tack J; Van Den Elzen B; Tytgat G; Wajs E; Van Nueten L; De Ridder F; Boeckxstaens G
    Neurogastroenterol Motil; 2009 Jun; 21(6):619-26, e23-4. PubMed ID: 19220756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.